Medpace Holdings Current Ratio 2014-2023 | MEDP
Current and historical current ratio for Medpace Holdings (MEDP) from 2014 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Medpace Holdings current ratio for the three months ending December 31, 2023 was 0.64.
| Medpace Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.59B | $0.93B | 0.64 |
| 2023-09-30 | $0.45B | $0.85B | 0.53 |
| 2023-06-30 | $0.38B | $0.85B | 0.45 |
| 2023-03-31 | $0.37B | $0.88B | 0.42 |
| 2022-12-31 | $0.33B | $0.80B | 0.42 |
| 2022-09-30 | $0.34B | $0.82B | 0.41 |
| 2022-06-30 | $0.33B | $0.88B | 0.37 |
| 2022-03-31 | $0.36B | $0.58B | 0.61 |
| 2021-12-31 | $0.69B | $0.56B | 1.24 |
| 2021-09-30 | $0.64B | $0.52B | 1.24 |
| 2021-06-30 | $0.55B | $0.47B | 1.16 |
| 2021-03-31 | $0.53B | $0.45B | 1.19 |
| 2020-12-31 | $0.47B | $0.44B | 1.08 |
| 2020-09-30 | $0.40B | $0.36B | 1.10 |
| 2020-06-30 | $0.32B | $0.34B | 0.94 |
| 2020-03-31 | $0.30B | $0.34B | 0.90 |
| 2019-12-31 | $0.32B | $0.34B | 0.92 |
| 2019-09-30 | $0.25B | $0.31B | 0.80 |
| 2019-06-30 | $0.19B | $0.30B | 0.66 |
| 2019-03-31 | $0.18B | $0.27B | 0.69 |
| 2018-12-31 | $0.18B | $0.26B | 0.69 |
| 2018-09-30 | $0.15B | $0.23B | 0.66 |
| 2018-06-30 | $0.16B | $0.23B | 0.68 |
| 2018-03-31 | $0.15B | $0.23B | 0.66 |
| 2017-12-31 | $0.13B | $0.19B | 0.67 |
| 2017-09-30 | $0.12B | $0.17B | 0.68 |
| 2017-06-30 | $0.12B | $0.16B | 0.79 |
| 2017-03-31 | $0.13B | $0.15B | 0.86 |
| 2016-12-31 | $0.13B | $0.17B | 0.79 |
| 2016-09-30 | $0.12B | $0.16B | 0.77 |
| 2016-06-30 | $0.00B | 0.00 | |
| 2016-03-31 | $0.00B | 0.00 | |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | 0.00 | |
| 2014-12-31 | $0.13B | $0.13B | 1.00 |
| 2013-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.458B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.615B | 15.64 |
| Cencora (COR) | United States | $45.231B | 17.63 |
| ICON (ICLR) | Ireland | $25.948B | 24.50 |
| DiDi Global (DIDIY) | China | $24.059B | 0.00 |
| Avantor (AVTR) | United States | $16.880B | 24.85 |
| CochLear (CHEOY) | Australia | $14.219B | 0.00 |
| Viatris (VTRS) | United States | $13.955B | 4.01 |
| Revvity (RVTY) | United States | $12.744B | 22.33 |
| Charles River Laboratories (CRL) | United States | $12.172B | 22.19 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.058B | 0.00 |
| Natera (NTRA) | United States | $11.732B | 0.00 |
| Solventum (SOLV) | United States | $11.310B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.460B | 0.00 |
| HealthEquity (HQY) | United States | $6.897B | 51.53 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.99 |
| Doximity (DOCS) | United States | $4.546B | 33.85 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.530B | 32.29 |
| Sotera Health (SHC) | United States | $3.247B | 15.93 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| GoodRx Holdings (GDRX) | United States | $2.974B | 150.60 |
| Life Times (LTH) | United States | $2.968B | 31.44 |
| Premier (PINC) | United States | $2.326B | 8.70 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.184B | 0.00 |
| Agilon Health (AGL) | United States | $2.047B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.967B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.671B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.481B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.314B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 8.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.607B | 4.01 |
| InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
| CareDx (CDNA) | United States | $0.543B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.529B | 0.00 |
| LifeMD (LFMD) | United States | $0.506B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.504B | 0.00 |
| Enhabit (EHAB) | United States | $0.497B | 45.00 |
| Auna S.A (AUNA) | Luxembourg | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.416B | 0.00 |
| ModivCare (MODV) | United States | $0.374B | 7.00 |
| DocGo (DCGO) | United States | $0.371B | 59.33 |
| Sera Prognostics (SERA) | United States | $0.307B | 0.00 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.178B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.17 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |